KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 99 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $91,997,000 | -2.5% | 9,496 | 0.0% | 0.05% | +96.3% |
| Q1 2022 | $94,384,000 | -22.2% | 9,496 | -7.9% | 0.03% | -6.9% |
| Q4 2021 | $121,309,000 | -1.1% | 10,307 | -4.3% | 0.03% | 0.0% |
| Q3 2021 | $122,700,000 | -6.6% | 10,773 | +13.3% | 0.03% | -3.3% |
| Q2 2021 | $131,356,000 | +8.1% | 9,505 | +44.8% | 0.03% | -14.3% |
| Q1 2021 | $121,494,000 | -12.6% | 6,564 | -16.5% | 0.04% | -14.6% |
| Q4 2020 | $138,933,000 | +71.7% | 7,863 | +48.8% | 0.04% | +78.3% |
| Q3 2020 | $80,931,000 | -25.3% | 5,283 | +24.3% | 0.02% | -20.7% |
| Q2 2020 | $108,283,000 | +18.8% | 4,250 | -27.8% | 0.03% | +16.0% |
| Q1 2020 | $91,173,000 | – | 5,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |